News

Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. Hence, we expect stable ...
Zacks Investment Research on MSN8dOpinion
5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025
The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...
Absci Corporation (NASDAQ:ABSI) is a leading biotechnology company revolutionizing the drug discovery and development process through the integration of artificial intelligence (AI) and synthetic ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Why ALZpath, GeneDX, 10x Genomics, Protagonist Therapeutics, and Recursion are among the most innovative biotech companies of 2025.
A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...
Find out what makes Basel's biotech hub so successful, as it has cemented its place as one of Europe's brightest life ...
More importantly, the index is down a massive 13.8% so far this year. Summit Therapeutics is a clinical-stage biotech company ...
NEW YORK, March 26, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company committed to the development and commercialization of best-in-class ...